Akebia Therapeutics, Inc. (AKBA)
1.585
-0.04
(-2.16%)
USD |
NASDAQ |
Dec 09, 16:00
1.585
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics EPS Diluted (Quarterly): 0.002 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Plus Therapeutics, Inc. | -0.0412 |
| Ironwood Pharmaceuticals, Inc. | 0.2294 |
| Pyxis Oncology, Inc. | -0.3517 |
| Karyopharm Therapeutics, Inc. | -3.821 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.54M |
| Revenue (Quarterly) | 58.77M |
| Total Expenses (Quarterly) | 58.23M |
| Enterprise Value | 475.05M |
| Gross Profit Margin (Quarterly) | 83.49% |
| Profit Margin (Quarterly) | 0.92% |
| Earnings Yield | -4.80% |
| Operating Earnings Yield | 4.45% |
| Normalized Earnings Yield | -3.596 |